ea0041ep548 | Diabetes therapy | ECE2016
Gouveia Ines
, Neves Celestino
, Oliveira Sofia
, Neves Joao Sergio
, Dias Claudia
, Carvalho Davide
Background: Continuous subcutaneous insulin infusion (CSII), alongside multiple daily injections (MDI) are the most frequent therapeutic of type 1 Diabetes Mellitus (DM). We aimed to evaluate the effects of the transition from MDI to CSII in the treatment of type 1 DM.Patients and methods: This retrospective longitudinal study analysed patients that received treatment with CSII from 2006 to 2014. Our sample had 85 patients, 35 male (41.2%) and 50 female ...